Clinical Trials Browser

Phase 2 × Has results × Combined Modality Therapy × Clear all

NCT01769508 2016-06-13

Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer

Phase 2 Terminated

12 enrolled 8 charts

Gastrointestinal

HER2 Positive Esophagogastric Cancer

NCT01226719 2015-05-27

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Phase 2 Completed

15 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms